| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Research and development | $157.7M+26.6% | $124.5M+44.6% | $86.1M+4.7% | $82.3M+61.0% | $51.1M+272.9% | $13.7M+249.6% | $3.9M |
| General and administrative | $21.0M+18.4% | $17.7M-5.7% | $18.8M-23.8% | $24.7M+21.2% | $20.4M+160.6% | $7.8M+1841.4% | $403K |
| Total operating expenses | $178.7M+25.6% | $142.3M+35.5% | $105.0M-1.9% | $107.0M+49.7% | $71.5M+232.1% | $21.5M+398.0% | $4.3M |
| Loss from operations | -$178.7M-25.6% | -$142.3M-35.5% | -$105.0M+1.9% | -$107.0M-49.7% | -$71.5M-232.1% | -$21.5M-398.0% | -$4.3M |
| Interest income | $16.2M+27.9% | $12.7M+52.3% | $8.3M+273.7% | $2.2M+404.1% | $442K+636.7% | $60K+757.1% | $7K |
| Other income | $23K-77.5% | $102K+636.8% | -$19K+29.6% | -$27K+42.6% | -$47K | — | — |
| Total other income | $16.2M+27.1% | $12.8M+53.9% | $8.3M+277.4% | $2.2M+457.2% | $395K+166.6% | -$593K-8571.4% | $7K |
| Net loss | -$162.5M-25.5% | -$129.5M-34.0% | -$96.7M+7.8% | -$104.8M-47.4% | -$71.1M-221.4% | -$22.1M-412.5% | -$4.3M |
| Net loss per share, basic (in dollars per share) | -$1870.00+15.0% | -$2200.00-2.8% | -$2140.00+18.3% | -$2620.00-145455.6% | -$1.80+47.4% | -$3.42-106.0% | -$1.66 |
| Net loss per share, diluted (in dollars per share) | -$1870.00+15.0% | -$2200.00-2.8% | -$2140.00+18.3% | -$2620.00-145455.6% | -$1.80+47.4% | -$3.42-106.0% | -$1.66 |
| Weighted average shares used to compute net loss per share, basic (in shares) | $87006027000.00+48.1% | $58743522000.00+29.8% | $45247098000.00+13.1% | $39995460000.00+101092.1% | $39524272.00+462.9% | $7021468.00+170.8% | $2593316.00 |
| Weighted average shares used to compute net loss per share, diluted (in shares) | $87006027000.00+48.1% | $58743522000.00+29.8% | $45247098000.00+13.1% | $39995460000.00+101092.1% | $39524272.00+462.9% | $7021468.00+170.8% | $2593316.00 |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.